Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $595.95

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus rating of “Moderate Buy” from the nineteen analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and thirteen have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $595.9524.

Several research firms recently commented on ISRG. Piper Sandler restated an “overweight” rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, July 26th.

Intuitive Surgical Trading Down 2.2%

Shares of ISRG stock opened at $469.88 on Friday. The company has a market capitalization of $168.44 billion, a price-to-earnings ratio of 65.53, a P/E/G ratio of 5.04 and a beta of 1.59. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00. The stock’s fifty day simple moving average is $505.14 and its 200-day simple moving average is $522.78.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the business earned $1.78 EPS. The business’s revenue for the quarter was up 21.4% on a year-over-year basis. On average, sell-side analysts predict that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the completion of the sale, the insider owned 18,520 shares of the company’s stock, valued at $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,839 shares of company stock valued at $7,896,972. 0.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently bought and sold shares of the stock. AlphaCore Capital LLC lifted its holdings in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Second Line Capital LLC increased its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock worth $302,000 after buying an additional 19 shares in the last quarter. Aaron Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after acquiring an additional 19 shares during the last quarter. Colonial Trust Co SC boosted its holdings in shares of Intuitive Surgical by 8.8% in the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider’s stock worth $128,000 after acquiring an additional 20 shares in the last quarter. Finally, Crown Wealth Group LLC grew its position in Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after acquiring an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.